ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
-0,80%
Bitcoin
67 214,90
-1,68%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Caribou Biosciences Inc (CRBU)

  7. Caribou Biosciences Inc (CRBU) Actualités

CRBU

Caribou Biosciences (CRBU)

Caribou Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CRBU
DateHeureSourceTitreSymboleSociété
30/05/202422h01GlobeNewswire Inc.Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
07/05/202422h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
07/05/202422h05GlobeNewswire Inc.Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
01/05/202422h05GlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
24/04/202416h00GlobeNewswire Inc.Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
15/04/202415h00GlobeNewswire Inc.Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)NASDAQ:CRBUCaribou Biosciences Inc
04/04/202422h00GlobeNewswire Inc.Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in LupusNASDAQ:CRBUCaribou Biosciences Inc
11/03/202422h08Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CRBUCaribou Biosciences Inc
11/03/202421h25Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRBUCaribou Biosciences Inc
11/03/202421h05GlobeNewswire Inc.Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
05/03/202422h30GlobeNewswire Inc.Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
22/02/202423h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
10/01/202422h18Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
09/01/202422h07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
08/01/202422h18Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRBUCaribou Biosciences Inc
07/01/202417h00GlobeNewswire Inc.Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024NASDAQ:CRBUCaribou Biosciences Inc
13/12/202312h30IH Market NewsCal-Maine Avian Flu Outbreak Impact, Amgen Hikes Dividend For Twelfth Year, and Latest UpdatesNASDAQ:CRBUCaribou Biosciences Inc
13/12/202300h26Dow Jones NewsCaribou Biosciences Shares Rise 4.1% as FDA Approves Lymphoma TrialNASDAQ:CRBUCaribou Biosciences Inc
12/12/202322h02GlobeNewswire Inc.Caribou Biosciences Provides Regulatory Update on CB-010 Pivotal Plan with Phase 3 Trial Initiation Expected by YE 2024NASDAQ:CRBUCaribou Biosciences Inc
17/11/202322h06Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
07/11/202322h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRBUCaribou Biosciences Inc
07/11/202322h00GlobeNewswire Inc.Caribou Biosciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
06/11/202314h00GlobeNewswire Inc.Caribou Biosciences Announces Appointment of Sundar Jagannath, MD, to its Scientific Advisory BoardNASDAQ:CRBUCaribou Biosciences Inc
18/10/202314h00GlobeNewswire Inc.Caribou Biosciences Announces FDA Clearance of IND Application for CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaNASDAQ:CRBUCaribou Biosciences Inc
27/09/202314h00GlobeNewswire Inc.Caribou Biosciences Appoints Reigin Zawadzki as Chief People OfficerNASDAQ:CRBUCaribou Biosciences Inc
08/08/202322h00GlobeNewswire Inc.Caribou Biosciences Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
14/07/202323h31Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CRBUCaribou Biosciences Inc
14/07/202322h22Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
14/07/202313h51IH Market NewsFriday’s Wall Street Highlights: JPMorgan Chase, Coinbase, UPS, Theseus Pharmaceuticals, and moreNASDAQ:CRBUCaribou Biosciences Inc
14/07/202305h15GlobeNewswire Inc.Caribou Biosciences Announces Pricing of Upsized $125 Million Public OfferingNASDAQ:CRBUCaribou Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CRBU

Dernières Valeurs Consultées

EU
HO
Thales
COIN
BTCUSD
Bitcoin
EU
CS
Axa
EU
AF
Air FranceKLM
EU
BNP
BNP Paribas
EU
BEL20
Bel 20
NASDAQ
GOOGL
Alphabet
EU
ACA
Credit Agricole
FTSE
UKX
FTSE 100
EU
GLE
Societe Generale
EU
SGO
Cie de SaintGobain
NASDAQ
AMZN
Amazon.com
NYSE
KO
Coca Cola
EU
PX4
SBF 120
NYSE
DIS
Walt Disney
EU
LR
Legrand
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés